Search Results - "Mukai, Yuji"

Refine Results
  1. 1
  2. 2

    Simultaneous Quantification of BCR-ABL and Bruton Tyrosine Kinase Inhibitors in Dried Plasma Spots and Its Application to Clinical Sample Analysis by Mukai, Yuji, Yoshida, Yuka, Yoshida, Tatsunari, Kondo, Takeshi, Inotsume, Nobuo, Toda, Takaki

    Published in Therapeutic drug monitoring (01-06-2021)
    “…Recent reports highlight the importance of therapeutic drug monitoring (TDM) of BCR-ABL and Bruton tyrosine kinase inhibitors (TKIs); thus, large-scale studies…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    The Inhibitory Effect of Telmisartan on the Metabolism of Arachidonic Acid by CYP2C9 and CYP2C8: An in Vitro Study by Kato, Yuka, Mukai, Yuji, Rane, Anders, Inotsume, Nobuo, Toda, Takaki

    “…Epoxyeicosatorienoic acids (EETs) are generated from arachidonic acid (AA) by CYPs. EETs comprise four regioisomers (14,15-, 11,12-, 8,9-, and 5,6-EET). EETs…”
    Get full text
    Journal Article
  6. 6

    Interior Temperature and Relative Humidity of an Envelope During Mail Transport by the Japan Post in the Summer: Preliminary Study for a Stability Test of Dried Blood Spot Samples Sent as Regular Mail by Mukai, Yuji, Minami, Rumiko, Doki, Kosuke, Inotsume, Nobuo, Toda, Takaki

    Published in Therapeutic drug monitoring (01-10-2019)
    “…The dried blood spot (DBS) is well studied and has been considered a useful technique for collecting biological specimens for therapeutic drug monitoring…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Co-administration of Fluvastatin and CYP3A4 and CYP2C8 Inhibitors May Increase the Exposure to Fluvastatin in Carriers of CYP2C9 Genetic Variants by Mukai, Yuji, Narita, Masayuki, Akiyama, Erika, Ohashi, Kanami, Horiuchi, Yasutaka, Kato, Yuka, Toda, Takaki, Rane, Anders, Inotsume, Nobuo

    “…Fluvastatin, which is one of the hydroxymethylglutaryl-CoA (HMG-CoA) reductase inhibitors (statins), is primarily metabolized by CYP2C9 and to a lesser extent…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Concentration of Sulfate and Glucuronide Conjugates of Ritodrine in Twin Pregnancy by Soma, Mayuko, Konda, Ainari, Fujieda, Satoko, Sasaki, Yoichi, Keira, Mitsuaki, Yoshida, Hiroshi, Mukai, Yuji, Toda, Takaki, Inotsume, Nobuo

    “…Ritodrine, a drug for the treatment of threatened premature labor, is a highly selective beta-2 agonist with the major metabolites of sulfate and glucuronide…”
    Get full text
    Journal Article
  11. 11

    Effects of Angiotensin II Receptor Blockers on Metabolism of Arachidonic Acid via CYP2C8 by Senda, Asuna, Mukai, Yuji, Toda, Takaki, Hayakawa, Toru, Yamashita, Miki, Eliasson, Erik, Rane, Anders, Inotsume, Nobuo

    “…Arachidonic acid (AA) is metabolized to epoxyeicosatrienoic acids (EETs) via cytochrome enzymes such as CYP 2C9, 2C8 and 2J2. EETs play a role in…”
    Get full text
    Journal Article
  12. 12

    Losartan Competitively Inhibits CYP2C8-Dependent Paclitaxel Metabolism in Vitro by Mukai, Yuji, Toda, Takaki, Hayakawa, Toru, Eliasson, Erik, Rane, Anders, Inotsume, Nobuo

    “…The present study aimed to characterize the inhibitory effects of losartan, an angiotensin II receptor blocker, on CYP2C8. Inhibition experiments were based on…”
    Get full text
    Journal Article
  13. 13

    Simultaneous Determination Method of Epoxyeicosatrienoic Acids and Dihydroxyeicosatrienoic Acids by LC-MS/MS System by Mukai, Yuji, Toda, Takaki, Takeuchi, Satoya, Senda, Asuna, Yamashita, Miki, Eliasson, Erik, Rane, Anders, Inotsume, Nobuo

    “…Epoxyeicosatrienoic acids (EETs) are produced primarily by CYPs from arachidonic acid (AA) and then further metabolized to the corresponding…”
    Get full text
    Journal Article
  14. 14

    Angiotensin II Receptor Blockers Inhibit the Generation of Epoxyeicosatrienoic Acid from Arachidonic Acid in Recombinant CYP2C9, CYP2J2 and Human Liver Microsomes by Senda, Asuna, Mukai, Yuji, Hayakawa, Toru, Kato, Yuka, Eliasson, Erik, Rane, Anders, Toda, Takaki, Inotsume, Nobuo

    Published in Basic & clinical pharmacology & toxicology (01-10-2017)
    “…Cytochrome P450 (CYP) 2C9, CYP2C8 and CYP2J2 enzymes, which metabolize arachidonic acid (AA) to epoxyeicosatrienoic acids, have cardioprotective effects…”
    Get full text
    Journal Article
  15. 15

    The Role of CYP2C8 and CYP2C9 Genotypes in Losartan‐Dependent Inhibition of Paclitaxel Metabolism in Human Liver Microsomes by Mukai, Yuji, Senda, Asuna, Toda, Takaki, Eliasson, Erik, Rane, Anders, Inotsume, Nobuo

    Published in Basic & clinical pharmacology & toxicology (01-06-2016)
    “…The aim of the present study was to further investigate a previously identified metabolic interaction between losartan and paclitaxel, which is one of the…”
    Get full text
    Journal Article
  16. 16
  17. 17

    An analytical method using salting‐out assisted liquid–liquid extraction to quantify ceftriaxone from micro volumes of human serum by Mukai, Yuji, Sugii, Narushi, Doki, Kosuke, Homma, Masato

    Published in Biomedical chromatography (01-09-2024)
    “…Ceftriaxone (CTRX) is a commonly used cephalosporin antibiotic. It is suggested that monitoring plasma/serum concentrations is helpful for its safe use. This…”
    Get full text
    Journal Article
  18. 18

    Pharmacokinetic study of erlotinib in a pregnant woman with advanced non‐small cell lung cancer and observation of the effects on the child growth by Aida, Yuka, Ohgami, Masahiro, Mukai, Yuji, Matsuyama, Masashi, Obata‐Yasuoka, Mana, Satoh, Toyomi, Homma, Masato, Sekine, Ikuo, Hizawa, Nobuyuki

    Published in British journal of clinical pharmacology (01-10-2024)
    “…Aims The aim of the study is to report the clinical and pharmacological observations from a pregnant patient treated with erlotinib in the second and third…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Combined effect of telmisartan and fluvastatin on arachidonic acid metabolism in human liver microsomes by Kato, Yuka, Mukai, Yuji, Rane, Anders, Inotsume, Nobuo, Toda, Takaki

    Published in Xenobiotica (02-09-2018)
    “…1. Epoxyeicosatrienoic acids (EETs), metabolites of arachidonic acid (AA) via cytochrome P450s, have a protective effect on the cardiovascular system involving…”
    Get full text
    Journal Article